Chemical Constitution, Pharmacological Effects and the Underlying Mechanism of Atractylenolides: A Review
Molecules · 09.05.2023 · 28 (10) · 3987
DOI: 10.3390/molecules28103987 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 09.05.2023. Verfasst von Zhiyi Xie und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou 310053, China. Hauptthemen laut MEDLINE: Phosphatidylinositol 3-Kinases, Atractylodes. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Key R&D Plan, The National Natural Science Foundation of China, Key R & D Program of Zhejiang Province.
Abstract (Originalsprache)
Atractylenolides, comprising atractylenolide I, II, and III, represent the principal bioactive constituents of Atractylodes macrocephala, a traditional Chinese medicine. These compounds exhibit a diverse array of pharmacological properties, including anti-inflammatory, anti-cancer, and organ-protective effects, underscoring their potential for future research and development. Recent investigations have demonstrated that the anti-cancer activity of the three atractylenolides can be attributed to their influence on the JAK2/STAT3 signaling pathway. Additionally, the TLR4/NF-κB, PI3K/Akt, and MAPK signaling pathways primarily mediate the anti-inflammatory effects of these compounds. Atractylenolides can protect multiple organs by modulating oxidative stress, attenuating the inflammatory response, activating anti-apoptotic signaling pathways, and inhibiting cell apoptosis. These protective effects extend to the heart, liver, lung, kidney, stomach, intestine, and nervous system. Consequently, atractylenolides may emerge as clinically relevant multi-organ protective agents in the future. Notably, the pharmacological activities of the three atractylenolides differ. Atractylenolide I and III demonstrate potent anti-inflammatory and organ-protective properties, whereas the effects of atractylenolide II are infrequently reported. This review systematically examines the literature on atractylenolides published in recent years, with a primary emphasis on their pharmacological properties, in order to inform future development and application efforts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou 310053, China.
- Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Huzhou 313200, China.
- Zhejiang Provincial Key Laboratory of TCM for Innovative R & D and Digital Intelligent Manufacturing of TCM Great Health Products, Huzhou 313200, China.
Förderung
- The National Key R&D Plan
- The National Natural Science Foundation of China
- Key R & D Program of Zhejiang Province
- Key R&D Program of Zhejiang Province
- The National Key R&D Plan
Zitieren
APA
Xie, Z., Lin, M., He, X., Dong, Y., Chen, Y., Li, B., Chen, S., & Lv, G. (2023). Chemical Constitution, Pharmacological Effects and the Underlying Mechanism of Atractylenolides: A Review. Molecules, 28(10), 3987. https://doi.org/10.3390/molecules28103987
Vancouver
Xie Z, Lin M, He X, Dong Y, Chen Y, Li B, et al. Chemical Constitution, Pharmacological Effects and the Underlying Mechanism of Atractylenolides: A Review. Molecules. 2023;28(10):3987. doi:10.3390/molecules28103987
BibTeX
@article{Xie2023,
author = {Xie, Zhiyi and Lin, Minqiu and He, Xinglishang and Dong, Yingjie and Chen, Yigong and Li, Bo and Chen, Suhong and Lv, Guiyuan},
title = {Chemical Constitution, Pharmacological Effects and the Underlying Mechanism of Atractylenolides: A Review},
journal = {Molecules},
year = {2023},
volume = {28},
number = {10},
pages = {3987},
doi = {10.3390/molecules28103987}
}
EUVIMED